Jerome D Goldberg

Array ( [id] => 1291685 [patent_doc_number] => 06630480 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-10-07 [patent_title] => 'Methods of treating leukemia' [patent_app_type] => B1 [patent_app_number] => 09/536459 [patent_app_country] => US [patent_app_date] => 2000-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4981 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 139 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/630/06630480.pdf [firstpage_image] =>[orig_patent_app_number] => 09536459 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7640195 [patent_doc_number] => 06395720 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-28 [patent_title] => 'Synergistically acting compositions for selectively combating tumor tissue' [patent_app_type] => B1 [patent_app_number] => 09/446570 [patent_app_country] => US [patent_app_date] => 2000-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3338 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/395/06395720.pdf [firstpage_image] =>[orig_patent_app_number] => 09446570 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1550057 [patent_doc_number] => 06346524 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-02-12 [patent_title] => 'Cancer treatment with temozolomide' [patent_app_type] => B1 [patent_app_number] => 09/535182 [patent_app_country] => US [patent_app_date] => 2000-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1440 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/346/06346524.pdf [firstpage_image] =>[orig_patent_app_number] => 09535182 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4327384 [patent_doc_number] => 06329412 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-11 [patent_title] => 'Bisamidine compounds as antiproliferative agents' [patent_app_type] => 1 [patent_app_number] => 9/535359 [patent_app_country] => US [patent_app_date] => 2000-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6084 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 150 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/329/06329412.pdf [firstpage_image] =>[orig_patent_app_number] => 535359 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1470318 [patent_doc_number] => 06407117 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-18 [patent_title] => 'Method of administering camptothecin compounds for the treatment of cancer with reduced side effects' [patent_app_type] => B1 [patent_app_number] => 09/534084 [patent_app_country] => US [patent_app_date] => 2000-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 14 [patent_no_of_words] => 11075 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/407/06407117.pdf [firstpage_image] =>[orig_patent_app_number] => 09534084 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1551164 [patent_doc_number] => 06399645 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-04 [patent_title] => 'Chemoprevention and treatment of cervical or vaginal neoplasia' [patent_app_type] => B1 [patent_app_number] => 09/531031 [patent_app_country] => US [patent_app_date] => 2000-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 2716 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/399/06399645.pdf [firstpage_image] =>[orig_patent_app_number] => 09531031 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4410038 [patent_doc_number] => 06300346 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-09 [patent_title] => 'Indenyl hydroxamic acids, (hydroxy) ureas and urethanes for treating patients with precancerous lesions' [patent_app_type] => 1 [patent_app_number] => 9/520667 [patent_app_country] => US [patent_app_date] => 2000-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13975 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 411 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/300/06300346.pdf [firstpage_image] =>[orig_patent_app_number] => 520667 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1289277 [patent_doc_number] => 06632795 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-10-14 [patent_title] => 'Dolastatin-15 derivatives in combination with taxanes' [patent_app_type] => B1 [patent_app_number] => 09/520254 [patent_app_country] => US [patent_app_date] => 2000-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 13765 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 783 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/632/06632795.pdf [firstpage_image] =>[orig_patent_app_number] => 09520254 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4379995 [patent_doc_number] => 06303596 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-16 [patent_title] => 'Use of taurolidine for treatment of leukemias' [patent_app_type] => 1 [patent_app_number] => 9/424426 [patent_app_country] => US [patent_app_date] => 2000-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 31 [patent_no_of_words] => 11617 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/303/06303596.pdf [firstpage_image] =>[orig_patent_app_number] => 424426 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1436026 [patent_doc_number] => 06355670 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-12 [patent_title] => 'Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions' [patent_app_type] => B1 [patent_app_number] => 09/511806 [patent_app_country] => US [patent_app_date] => 2000-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17674 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/355/06355670.pdf [firstpage_image] =>[orig_patent_app_number] => 09511806 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1411973 [patent_doc_number] => 06528524 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-03-04 [patent_title] => 'Pharmaceutical compositions containing cinchonine dichlorhydrate' [patent_app_type] => B2 [patent_app_number] => 09/424943 [patent_app_country] => US [patent_app_date] => 2000-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2016 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/528/06528524.pdf [firstpage_image] =>[orig_patent_app_number] => 09424943 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1291564 [patent_doc_number] => 06630464 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-10-07 [patent_title] => 'Cyclin dependent kinase (CDK)4 inhibitors and their use for treating cancer' [patent_app_type] => B1 [patent_app_number] => 09/403659 [patent_app_country] => US [patent_app_date] => 2000-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 47 [patent_figures_cnt] => 71 [patent_no_of_words] => 6676 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/630/06630464.pdf [firstpage_image] =>[orig_patent_app_number] => 09403659 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1507986 [patent_doc_number] => 06440998 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-27 [patent_title] => 'Pharmaceutical composition having enhanced antitumor activity and/or reduced side effects, containing an antitumor agent and an hydroximic acid derivative' [patent_app_type] => B1 [patent_app_number] => 09/446064 [patent_app_country] => US [patent_app_date] => 2000-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5880 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/440/06440998.pdf [firstpage_image] =>[orig_patent_app_number] => 09446064 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4328980 [patent_doc_number] => 06319923 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-20 [patent_title] => 'Method of treating a tumor' [patent_app_type] => 1 [patent_app_number] => 9/505043 [patent_app_country] => US [patent_app_date] => 2000-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4954 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/319/06319923.pdf [firstpage_image] =>[orig_patent_app_number] => 505043 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7636490 [patent_doc_number] => 06380167 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-30 [patent_title] => 'Methods for anti-tumor therapy' [patent_app_type] => B1 [patent_app_number] => 09/502544 [patent_app_country] => US [patent_app_date] => 2000-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11924 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/380/06380167.pdf [firstpage_image] =>[orig_patent_app_number] => 09502544 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1521321 [patent_doc_number] => 06414014 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-02 [patent_title] => 'Method for administration of taxol' [patent_app_type] => B1 [patent_app_number] => 09/499373 [patent_app_country] => US [patent_app_date] => 2000-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7694 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 110 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/414/06414014.pdf [firstpage_image] =>[orig_patent_app_number] => 09499373 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4406435 [patent_doc_number] => 06271221 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-07 [patent_title] => 'Use of equilenin as an antioxidant' [patent_app_type] => 1 [patent_app_number] => 9/498563 [patent_app_country] => US [patent_app_date] => 2000-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2896 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/271/06271221.pdf [firstpage_image] =>[orig_patent_app_number] => 498563 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1454076 [patent_doc_number] => 06462064 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-08 [patent_title] => 'Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents, especially for cervical cancers and dysplasias' [patent_app_type] => B1 [patent_app_number] => 09/498347 [patent_app_country] => US [patent_app_date] => 2000-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 14 [patent_no_of_words] => 14091 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/462/06462064.pdf [firstpage_image] =>[orig_patent_app_number] => 09498347 [rel_patent_id] =>[rel_patent_doc_number] =>)